[Antihypertensive effect of isradipine: blood pressure determination with continuous ambulatory monitoring].
A 24 hr blood pressure monitoring system (Medilog ABP) was used to evaluate the efficacy of isradipine, 2.5 mg q 12 hr for 2 weeks, in 26 hypertensive patients. During a pretreatment control period of 4 weeks a diastolic pressure above 95 mmHg on non pharmacologic measures was verified in each patient. A significant decrease in systolic and diastolic blood pressures compared at 2 hr intervals was observed after treatment with isradipine. Treatment was not associated to modification of the circadian rythm in blood pressures.
Fasce
E
E
Departamento de Medicina Interna, Facultad de Medicina, Universidad de Concepción, Chile.
Lecannelier
E
E
D001795:Blood Pressure Determination / Q000379:methods*; D015924:Blood Pressure Monitors; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D017275:Isradipine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D017275:Isradipine
Efecto antihipertensivo de isradipino: evaluación con monitorización ambulatoria continua de la presión arterial.